CompletedNCT01511640
Pregabalin or Placebo and the Effects of Cannabis
About this title
Read the official source — NCT01511640Medication studyAges 18–50United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- LexingtonSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Study information
Study start dateStarted: February 1, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- Joshua A. Lile, Ph.D.
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT01511640
- Official title
Show the full official title
Behavioral Effects of Drugs (Outpatient)(43)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Lexington
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Joshua A. Lile, Ph.D.
Did this study involve medication?
Yes. The study involved medication, including Pregabalin and Placebo.
Who was this study for?
Listed age limits: 18 years to 50 years.
